Vizioli Omics

Vizioli Omics is a for-profit international organization registered in SAM.gov with an active federal vendor registration valid through November 11, 2025. The company appears to be a specialized research and data analysis firm focused on complex scientific research, particularly in the domains of clinical, microbiome, and metabolomic data integration. While specific details about the company's full organizational background are not provided, the available federal contract data suggests they are a highly specialized scientific research and analysis service provider.

The company has exclusively been awarded purchase order contracts from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH). These contracts, ranging from $24,876 to $25,000, have consistently focused on statistical analysis of integrated clinical, microbiome, and metabolome data. Specifically, Vizioli Omics has performed services including comprehensive data analysis, manuscript preparation, and manuscript submission for research projects. The contracts have involved preparing research documentation with detailed components such as introduction, materials and methods, results, figures, tables, discussion, and conclusions. All three identified federal contract awards were firm fixed-price purchase orders with no specific set-aside designations, indicating open competition. The performance periods for these contracts have ranged from January 2023 to June 2025, demonstrating ongoing engagement with NIDA for specialized scientific research support.